Erythema News and Research

RSS
Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Martindale Pharma announces UK launch of Prenoxad Injection for opioid overdose

Martindale Pharma announces UK launch of Prenoxad Injection for opioid overdose

FDA grants orphan-drug designation to XEN402 for treatment of pain associated with EM

FDA grants orphan-drug designation to XEN402 for treatment of pain associated with EM

Nuvo Research reaches another milestone with the launch of Pliaglis in Europe

Nuvo Research reaches another milestone with the launch of Pliaglis in Europe

New study to discover preventive use of antibiotics for Lyme disease

New study to discover preventive use of antibiotics for Lyme disease

Regeneron, Sanofi announce pooled data from Phase 1b trials with dupilumab for atopic dermatitis

Regeneron, Sanofi announce pooled data from Phase 1b trials with dupilumab for atopic dermatitis

FDA approves Genzyme’s KYNAMRO to treat homozygous familial hypercholesterolemia

FDA approves Genzyme’s KYNAMRO to treat homozygous familial hypercholesterolemia

Celgene announces results from REVLIMID plus VIDAZA phase II study on AML

Celgene announces results from REVLIMID plus VIDAZA phase II study on AML

CSL, PharmaJet partner for needle-free delivery of Afluria influenza vaccine

CSL, PharmaJet partner for needle-free delivery of Afluria influenza vaccine

UCB to sponsor key sets of VIMPAT C-V data at 66th American Epilepsy Society annual meeting

UCB to sponsor key sets of VIMPAT C-V data at 66th American Epilepsy Society annual meeting

NICE decides to recommend Bristol-Myers Squibb’s YERVOY for treatment of advanced melanoma

NICE decides to recommend Bristol-Myers Squibb’s YERVOY for treatment of advanced melanoma

Durata completes target enrollment in dalbavancin Phase 3 trial for ABSSSI

Durata completes target enrollment in dalbavancin Phase 3 trial for ABSSSI

Sanofi presents overview of Phase II and III trials for quadrivalent influenza vaccine

Sanofi presents overview of Phase II and III trials for quadrivalent influenza vaccine

Sanofi Pasteur files Fluzone sBLA with FDA for treatment of influenza

Sanofi Pasteur files Fluzone sBLA with FDA for treatment of influenza

Sun protection: an interview with Jane Hanrahan

Sun protection: an interview with Jane Hanrahan

RXi completes dosing in RXI-109 Phase 1 study for dermal scarring

RXi completes dosing in RXI-109 Phase 1 study for dermal scarring

Durata completes target enrollment in dalbavancin Phase 3 trials for abSSSI

Durata completes target enrollment in dalbavancin Phase 3 trials for abSSSI

Rigel commences R343 and R333 Phase 2 studies in allergic asthma, discoid lupus erythematosus

Rigel commences R343 and R333 Phase 2 studies in allergic asthma, discoid lupus erythematosus

FDA approves Novartis’ Exelon Patch to treat mild to moderate AD

FDA approves Novartis’ Exelon Patch to treat mild to moderate AD

Soft implants preferable for nose augmentation

Soft implants preferable for nose augmentation